Statement from Ashok Leyland on transition to BS IV norm
Mr. Vinod K. Dasari, MD and CEO, Ashok Leyland Ltd. “Contrary to the various reports in the media about Ashok Leyland having to take a huge write-off of BS III inventories, the Company clarifies that […]